Rights and permissions
About this article
Cite this article
Irbesartan cost effective for treatment of kidney disease in type 2 DM. Pharmacoecon. Outcomes News 391, 6 (2002). https://doi.org/10.1007/BF03279931
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279931